Igor Bilinsky
Chief Operating Officer at IOVANCE BIOTHERAPEUTICS, INC.
Net worth: 563 545 $ as of 2024-03-30
Profile
Igor P. Bilinsky holds the position of Chief Operating Officer of Iovance Biotherapeutics, Inc. Dr. Bilinsky previously occupied the position of Chief Executive Officer at Androclus Therapeutics, Inc., VP-Business Development & Special Operations at Halozyme Therapeutics, Inc., Principal at The Boston Consulting Group, Inc., Chief Business Officer for Oncternal Therapeutics, Inc., Chief Operating Officer & Senior Vice President of AmpliPhi Biosciences Corp., Head-Research & Development at Symyx Technologies, Inc., Senior Vice President-Corporate Development for Vical, Inc. and Senior VP-Special Operations, GM-Immuno & Oncology at Ignyta, Inc. Igor P. Bilinsky received an undergraduate degree from Moscow Institute of Physics & Technology and a doctorate from Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-14 | 38,026 ( 0.01% ) | 563 545 $ | 2024-03-30 |
Igor Bilinsky active positions
| Companies | Position | Start |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Operating Officer | 2021-03-14 |
Former positions of Igor Bilinsky
| Companies | Position | End |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-02-28 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Chief Operating Officer | 2019-01-13 |
| IGNYTA INC | Corporate Officer/Principal | 2016-12-31 |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 2009-12-31 |
| Androclus Therapeutics, Inc. | Chief Executive Officer | 2006-12-31 |
Training of Igor Bilinsky
| Massachusetts Institute of Technology | Doctorate Degree |
| Moscow Institute of Physics & Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Symyx Technologies, Inc.
 Symyx Technologies, Inc. Packaged SoftwareTechnology Services Symyx Technologies, Inc. develops and applies high-throughput experimentation to the discovery of materials for chemical and petrochemical, pharmaceutical development, electronics, consumer goods and automotive customers. The company works together with companies seeking to transform their search for better products and processes through research collaborations and Discovery Tools sales and the license of materials, intellectual property and software. The company was incorporated in February 1999 and is headquartered in Sunnyvale, CA. | Technology Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
| Androclus Therapeutics, Inc. | |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Igor Bilinsky
